​
​

Bausch + Lomb (BLCO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BLCO Stock Forecast

Bausch + Lomb stock forecast is as follows: an average price target of $22.29 (represents a 12.52% upside from BLCO’s last price of $19.81) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.

BLCO Price Target

The average price target for Bausch + Lomb (BLCO) is $22.29 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $25.00 to $18.00. This represents a potential 12.52% upside from BLCO's last price of $19.81.

BLCO Analyst Ratings

Buy

According to 9 Wall Street analysts, Bausch + Lomb's rating consensus is 'Buy'. The analyst rating breakdown for BLCO stock is 0 'Strong Buy' (0.00%), 8 'Buy' (88.89%), 1 'Hold' (11.11%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Bausch + Lomb Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 31, 2024Yi ChenH.C. Wainwright--12.52%16.10%
Oct 22, 2024Doug MiehmRBC Capital--11.22%16.10%
Oct 15, 2024Larry BiegelsenWells Fargo--10.21%16.10%
Oct 15, 2024Vijay KumarEvercore ISI--19.79%26.20%
Sep 23, 2024Tom StephanStifel Nicolaus---4.28%-4.09%
Sep 19, 2024Zachary WeinerJefferies--24.66%26.20%
Jul 22, 2024Doug MiehmRBC Capital--17.79%0.96%
May 06, 2024Patrick WoodMorgan Stanley--32.35%-9.14%
May 08, 2023Yi ChenH.C. Wainwright--4.65%-4.09%
Jul 28, 2022Vijay KumarEvercore ISI--41.32%6.01%
Row per page
Go to

The latest Bausch + Lomb stock forecast, released on Oct 31, 2024 by Yi Chen from H.C. Wainwright, set a price target of $23.00, which represents a 12.52% increase from the stock price at the time of the forecast ($20.44), and a 16.10% increase from BLCO last price ($19.81).

Bausch + Lomb Price Target by Period

1M3M12M
# Anlaysts268
Avg Price Target$23.00$23.00$22.00
Last Closing Price$19.81$19.81$19.81
Upside/Downside16.10%16.10%11.06%

In the current month, the average price target of Bausch + Lomb stock is $23.00, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 16.10% increase as opposed to Bausch + Lomb's last price of $19.81. This month's average price target is down 0.00% compared to last quarter, and up 4.55% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 31, 2024CitigroupBuyBuyHold
Oct 31, 2024H.C. WainwrightBuyBuyHold
Oct 22, 2024RBC CapitalOutperformOutperformHold
Oct 15, 2024Wells FargoOverweightOverweightHold
Oct 15, 2024Evercore ISIPositiveOutperformUpgrade
Oct 01, 2024Evercore ISIPositivePositiveHold
Sep 23, 2024H.C. WainwrightBuyBuyHold
Sep 19, 2024JefferiesBuyBuyHold
Jul 22, 2024RBC CapitalOutperformOutperformHold
Jul 10, 2024Raymond JamesOutperformInitialise
Row per page
Go to

Bausch + Lomb's last stock rating was published by Citigroup on Oct 31, 2024. The company gave BLCO a "Buy" rating, the same as its previous rate.

Bausch + Lomb Financial Forecast

Bausch + Lomb Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Revenue---------$1.01B$1.03B$931.00M$996.00M$942.00M$941.00M$889.00M
Avg Forecast$1.34B$1.27B$1.29B$1.17B$1.26B$1.17B$1.17B$1.06B$1.11B$990.68M$963.69M$895.80M$966.92M$949.72M$908.52M$889.00M
High Forecast$1.38B$1.30B$1.32B$1.22B$1.28B$1.17B$1.17B$1.06B$1.14B$1.02B$993.01M$923.06M$996.35M$949.72M$908.52M$889.00M
Low Forecast$1.32B$1.25B$1.27B$1.15B$1.24B$1.17B$1.17B$1.06B$1.09B$974.14M$948.75M$881.91M$951.93M$949.72M$908.52M$889.00M
# Analysts44461093368544343
Surprise %---------1.02%1.07%1.04%1.03%0.99%1.04%1.00%

Bausch + Lomb's average Quarter revenue forecast for Dec 23 based on 6 analysts is $1.11B, with a low forecast of $1.09B, and a high forecast of $1.14B. BLCO's average Quarter revenue forecast represents a 9.85% increase compared to the company's last Quarter revenue of $1.01B (Sep 23).

Bausch + Lomb EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts44461093368544343
EBITDA---------$40.00M$43.00M$58.00M$110.00M$147.00M$154.00M$151.00M
Avg Forecast$258.74M$244.82M$248.55M$225.48M$243.58M$226.86M$226.44M$205.59M$213.96M$191.61M$186.38M$173.25M$187.01M$182.25M$104.59M$170.60M
High Forecast$266.61M$252.27M$256.12M$235.12M$247.42M$227.06M$226.44M$205.59M$220.47M$196.70M$192.06M$178.53M$192.70M$182.25M$125.50M$170.60M
Low Forecast$254.72M$241.02M$244.70M$221.63M$239.75M$226.67M$226.44M$205.59M$210.64M$188.41M$183.50M$170.57M$184.11M$182.25M$83.67M$170.60M
Surprise %---------0.21%0.23%0.33%0.59%0.81%1.47%0.89%

6 analysts predict BLCO's average Quarter EBITDA for Dec 23 to be $213.96M, with a high of $220.47M and a low of $210.64M. This is 434.89% upper than Bausch + Lomb's previous annual EBITDA (Sep 23) of $40.00M.

Bausch + Lomb Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts44461093368544343
Net Income---------$-84.00M$-32.00M$-88.00M-$-15.00M$7.00M$20.00M
Avg Forecast$97.05M$80.55M$76.18M$49.16M$84.97M$55.65M$45.47M$24.90M$59.89M$66.56M$51.55M$47.91M$78.91M$84.02M$3.13M$82.32M
High Forecast$100.89M$83.73M$79.19M$68.28M$99.75M$55.88M$45.56M$24.96M$73.98M$81.92M$53.58M$49.81M$82.03M$84.02M$3.76M$82.32M
Low Forecast$95.09M$78.92M$74.64M$32.78M$77.59M$55.43M$45.38M$24.83M$42.27M$40.96M$50.51M$46.95M$77.32M$84.02M$2.51M$82.32M
Surprise %----------1.26%-0.62%-1.84%--0.18%2.24%0.24%

Bausch + Lomb's average Quarter net income forecast for Sep 22 is $84.02M, with a range of $84.02M to $84.02M. BLCO's average Quarter net income forecast represents a 1100.24% increase compared to the company's last Quarter net income of $7.00M (Jun 22).

Bausch + Lomb SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts44461093368544343
SG&A---------$418.00M$417.00M$418.00M$386.00M$381.00M$368.00M$343.00M
Avg Forecast$511.81M$484.28M$491.67M$446.03M$481.84M$448.77M$447.92M$406.68M$423.23M$379.02M$368.69M$342.72M$369.93M$363.35M$230.46M$340.12M
High Forecast$527.39M$499.02M$506.63M$465.09M$489.43M$449.15M$447.92M$406.68M$436.11M$389.09M$379.91M$353.15M$381.19M$363.35M$276.56M$340.12M
Low Forecast$503.88M$476.77M$484.05M$438.41M$474.25M$448.38M$447.92M$406.68M$416.67M$372.69M$362.98M$337.41M$364.20M$363.35M$184.37M$340.12M
Surprise %---------1.10%1.13%1.22%1.04%1.05%1.60%1.01%

Bausch + Lomb's average Quarter SG&A projection for Dec 23 is $423.23M, based on 6 Wall Street analysts, with a range of $416.67M to $436.11M. The forecast indicates a 1.25% rise compared to BLCO last annual SG&A of $418.00M (Sep 23).

Bausch + Lomb EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts44461093368544343
EPS---------$-0.24$-0.09$-0.25-$-0.04$0.02$0.06
Avg Forecast$0.27$0.23$0.22$0.14$0.24$0.16$0.13$0.07$0.17$0.19$0.15$0.14$0.22$0.24$0.20$0.23
High Forecast$0.29$0.24$0.22$0.19$0.28$0.16$0.13$0.07$0.21$0.23$0.15$0.14$0.23$0.24$0.20$0.23
Low Forecast$0.27$0.22$0.21$0.09$0.22$0.16$0.13$0.07$0.12$0.12$0.14$0.13$0.22$0.24$0.20$0.23
Surprise %----------1.28%-0.63%-1.85%--0.18%0.10%0.24%

According to 3 Wall Street analysts, Bausch + Lomb's projected average Quarter EPS for Sep 22 is $0.24, with a low estimate of $0.24 and a high estimate of $0.24. This represents a 1094.10% increase compared to BLCO previous annual EPS of $0.02 (Jun 22).

Bausch + Lomb Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
COOCooper Companies--198.27%Buy
AKYAAkoya Biosciences--150.00%Buy
ANGOAngioDynamics--115.83%Buy
TFXTeleflex--59.65%Buy
ATRCAtriCure--38.93%Buy
HAEHaemonetics--26.71%Buy
BDXBecton, Dickinson and Company--25.65%Buy
BLCOBausch + Lomb--12.52%Buy
ALCAlcon--9.72%Buy
HOLXHologic--1.89%Buy
ICUIICU Medical--1.87%Buy
WSTWest Pharmaceutical Services---7.23%Buy
RMDResMed---10.05%Hold
ATRAptarGroup---18.77%Buy

BLCO Forecast FAQ

Is Bausch + Lomb a good buy?

Yes, according to 9 Wall Street analysts, Bausch + Lomb (BLCO) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 8 'Buy' recommendations, accounting for 88.89% of BLCO's total ratings.

What is BLCO's price target?

Bausch + Lomb (BLCO) average price target is $22.29 with a range of $18 to $25, implying a 12.52% from its last price of $19.81. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Bausch + Lomb stock go up soon?

According to Wall Street analysts' prediction for BLCO stock, the company can go up by 12.52% (from the last price of $19.81 to the average price target of $22.29), up by 26.20% based on the highest stock price target, and down by -9.14% based on the lowest stock price target.

Can Bausch + Lomb stock reach $30?

BLCO's average twelve months analyst stock price target of $22.29 does not support the claim that Bausch + Lomb can reach $30 in the near future.

What is Bausch + Lomb's current price target trend?

2 Wall Street analysts forecast a $23 price target for Bausch + Lomb (BLCO) this month, up 16.10% from its last price of $19.81. Compared to the last 3 and 12 months, the average price target increased by 16.10% and increased by 11.06%, respectively.

What are Bausch + Lomb's analysts' financial forecasts?

Bausch + Lomb's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $4.67B (high $4.69B, low $4.65B), average EBITDA is $902.48M (high $906.51M, low $898.45M), average net income is $211M (high $226.15M, low $203.23M), average SG&A $1.79B (high $1.79B, low $1.78B), and average EPS is $0.596 (high $0.639, low $0.574). BLCO's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $5.05B (high $5.22B, low $4.97B), average EBITDA is $977.59M (high $1.01B, low $962.08M), average net income is $302.93M (high $332.09M, low $281.43M), average SG&A $1.93B (high $2B, low $1.9B), and average EPS is $0.856 (high $0.938, low $0.795).

Did the BLCO's actual financial results beat the analysts' financial forecasts?

Based on Bausch + Lomb's last annual report (Dec 2022), the company's revenue was $3.77B, beating the average analysts forecast of $3.71B by 1.45%. Apple's EBITDA was $457M, missing the average prediction of $644.45M by -29.09%. The company's net income was $15M, missing the average estimation of $248.38M by -93.96%. Apple's SG&A was $1.48B, beating the average forecast of $1.3B by 13.36%. Lastly, the company's EPS was $0.0429, missing the average prediction of $0.892 by -95.19%. In terms of the last quarterly report (Sep 2023), Bausch + Lomb's revenue was $1.01B, beating the average analysts' forecast of $990.68M by 1.65%. The company's EBITDA was $40M, missing the average prediction of $191.61M by -79.12%. Bausch + Lomb's net income was $-84M, missing the average estimation of $66.56M by -226.20%. The company's SG&A was $418M, beating the average forecast of $379.02M by 10.28%. Lastly, the company's EPS was $-0.24, missing the average prediction of $0.188 by -227.61%